Homepage
Eventi
Corsi FAD
News
Login
Accedi
Registrati
Recupera password
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
26 dicembre 2021
Senza categoria
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
0
out of
5
based on
0
user ratings
Journal of Clinical Oncology, Ahead of Print.
Related Posts
Lascia un commento
Annulla risposta
Devi essere
connesso
per inviare un commento.